ASTRAZENECA PLC
AZN · NYSE
Updated at 2026-10-13 13:44:08
- Today's High
- $160.83
- Today’s Low
- $159.42
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $159.44
- Previous Close
- $158.33
- Volume
- 2.85M
- Market Cap
- $186.07B
- P/E Ratio
- 23.57X
- EPS
- $6.68
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - GENERAL
- Headquarters
- 1 FRANCIS CRICK AVENUE, CAMBRIDGE, UNITED KINGDOM, CB2 0AA
- Country
- GB
- Listing Date
- 2007-09-21
- Fiscal Year End
- December
- Shares Outstanding
- 1.55B
- CIK
- 0000901832
- Website
- www.astrazeneca.com
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.
Financial Metrics
Revenue
2026-06-30
$15.38B
2026-03-31
$15.28B
2025-12-31
$15.5B
2025-09-30
$15.19B
Operating Expenses
2026-06-30
$9.69B
2026-03-31
$8.36B
2025-12-31
$9.4B
2025-09-30
$8.8B
Net Income
2026-06-30
$2.5B
2026-03-31
$3.08B
2025-12-31
$2.32B
2025-09-30
$2.53B
Net Profit Margin
2026-06-30
16.29%
2026-03-31
20.14%
2025-12-31
15%
2025-09-30
16.67%
Earnings Per Share
2026-06-30
$2.63
2026-03-31
$1.29
2025-12-31
--
2025-09-30
$1.19
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$5.16B
2026-03-31
$5.67B
2025-12-31
$4.63B
2025-09-30
$5.22B
Effective Tax Rate
2026-06-30
10.39%
2026-03-31
21.28%
2025-12-31
11.41%
2025-09-30
21.85%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $15.38B | $15.28B | $15.5B | $15.19B |
| Operating Expenses | $9.69B | $8.36B | $9.4B | $8.8B |
| Net Income | $2.5B | $3.08B | $2.32B | $2.53B |
| Net Profit Margin | 16.29% | 20.14% | 15% | 16.67% |
| Earnings Per Share | $2.63 | $1.29 | -- | $1.19 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $5.16B | $5.67B | $4.63B | $5.22B |
| Effective Tax Rate | 10.39% | 21.28% | 11.41% | 21.85% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.